26 July 2017 | News
The companies’ continued collaborations will focus on additional evaluations and the deployment of a new innovation.
Merck, Pfizer and Corning Incorporated have announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor Glass. This revolutionary pharmaceutical glass packaging solution enhances the storage and delivery of today’s drug formulations and provides more reliable access to medicines essential to public health.
Deep pharmaceutical formulation and manufacturing process insights from Merck and Pfizer, in combination with Corning’s glass science and precision forming capabilities helped deliver an exceptional glass packaging solution for injectable drugs in vials and cartridges. The companies’ continued collaborations will focus on additional evaluations and the deployment of this new innovation.
Corning Valor Glass packaging offers superior chemical durability, strength and damage resistance. These qualities enable increased throughput and more reliable access to state-of-the-art medicines for patients, while maintaining a high level of quality assurance for pharmaceutical companies.
As a result of Merck and Pfizer’s commitment to improving glass quality and promising results from their initial testing, Corning is making an initial investment of $500 million and creating 1,000 new US jobs as the first part of a planned investment of $4 billion and 4,000 new high-tech jobs.